Friday turned out to be a big day for Tiger Cub Andreas Halvorsen’s Viking Global Investors, with two IPOs in which the hedge fund held large stakes rocketing on their first day of trading.
Meanwhile, another biopharma in which it holds a smaller position has more than doubled in price since it went public a little more than a week ago.
